- The Exam Snapshot: Numbers You Must Know
- All 19 Domains and Their Weights
- High-Yield Core: Asthma, Symptoms, and Diagnostics
- Airway and Lung Disease Facts to Memorize
- Neonatal, Respiratory Failure, and Sleep/Control of Breathing
- Smaller Domains That Still Cost Points
- Scheduling Your Review by Domain Weight
- Registration, Fees, and Eligibility Mechanics
- Frequently Asked Questions
- The ABP certification exam has roughly 200 multiple-choice questions and a passing scaled score of 180 on a 1-300 scale, not a raw percentage.
- The 19-domain outline effective November 1, 2026 applies to the November 5, 2026 initial-certification examination.
- Asthma is the single largest published domain at 9%, followed by Common Signs and Symptoms and Core Diagnostic Principles at 8% each.
- The latest verified first-time national pass rate is 73% (2024), up from 68% in 2022.
The Exam Snapshot: Numbers You Must Know
This page condenses what a candidate for Certification in Pediatric Pulmonology needs on a single screen: how the exam is built, how it is scored, and where the points concentrate. The credential is administered by the American Board of Pediatrics (ABP), and testing is delivered through Prometric. Nothing here applies to any other credential that happens to share a similar name.
| Item | What to Remember |
|---|---|
| Certifying body | American Board of Pediatrics (ABP) |
| Test delivery | Prometric |
| Format | Approximately 200 multiple-choice questions |
| Passing standard | Scaled score of 180 on a 1-300 scale (not a raw percentage) |
| Latest verified first-time national pass rate | 73% in 2024 (68% in 2022), per a 2026 primary paper citing ABP |
| Official indexed regular fee | $2,992, including $750 processing |
| Outline in force for the next sitting | 19 domains, effective November 1, 2026 |
| Next initial-certification exam | November 5, 2026 |
| Continuing certification | Five-year cycle; MOCA-Peds or an examination pathway |
On the pass rate: the 73% first-time figure is a national number reported for 2024. It is encouraging, but it describes a cohort, not your odds. Our breakdown of what the pass-rate data shows explains how to interpret it without over- or under-confidence.
All 19 Domains and Their Weights
The content outline effective November 1, 2026 lists 19 domains with approximate published weights that total 100%. Versions of the outline may vary slightly, so always confirm against the official ABP document at abp.org. Note that the October 2025 subboard approval date is not the effective date; the November 1, 2026 date is what governs the upcoming exam.
| # | Domain | Weight |
|---|---|---|
| 1 | Lung Development and Physiology | 6% |
| 2 | Common Signs and Symptoms | 8% |
| 3 | Respiratory Disorders of the Neonate and Infant | 5% |
| 4 | Congenital and Acquired Malformations of the Airways and Lungs | 5% |
| 5 | Respiratory Infections | 6% |
| 6 | Cystic Fibrosis (CF) | 6% |
| 7 | Non-CF Bronchiectasis | 4% |
| 8 | Asthma | 9% |
| 9 | Sleep-Disordered Breathing and Control of Breathing Disorders | 4% |
| 10 | Restrictive Disease | 5% |
| 11 | Respiratory Failure | 5% |
| 12 | Interstitial Lung Disease | 5% |
| 13 | Pulmonary Vascular and Lymphatic Diseases | 4% |
| 14 | Lung Disease Associated with Systemic Disorders | 4% |
| 15 | Environmental Injuries and Exposures (Acute and Chronic) | 4% |
| 16 | Respiratory System Under Stress | 3% |
| 17 | Other Disorders of the Respiratory System | 5% |
| 18 | Core Principles of Pulmonary Diagnosis and Monitoring Techniques | 8% |
| 19 | Core Knowledge in Scholarly Activities and Health Equity | 4% |
Three observations from the table. First, the distribution is fairly flat: no domain exceeds 9%, so there is no single topic you can safely skip. Second, the three largest domains (Asthma at 9%, Common Signs and Symptoms at 8%, and Core Principles of Pulmonary Diagnosis and Monitoring Techniques at 8%) together account for roughly a quarter of the exam. Third, the smallest domain, Respiratory System Under Stress at 3%, is still worth several questions on a 200-item exam. For the full narrative treatment of each area, see the complete guide to all 19 content areas.
High-Yield Core: Asthma, Symptoms, and Diagnostics
Asthma (9%)
Asthma: The Largest Published Domain
Expect questions that test management decisions rather than definitions. Be ready to reason through stepwise therapy, control assessment, and the differential for "asthma that isn't responding."
- Distinguish severity (untreated baseline) from control (response to therapy) and know how each drives step-up or step-down decisions.
- Know when poor response should prompt reconsideration: adherence, inhaler technique, environmental triggers, comorbid rhinitis or reflux, vocal cord dysfunction, and alternative diagnoses.
- Understand the role and limits of biologic therapy for severe disease, including how phenotype guides selection.
- Review acute exacerbation management, including adjuncts and the indications for escalating care.
Common Signs and Symptoms (8%)
This domain rewards symptom-to-diagnosis reasoning. Chronic cough, wheeze, stridor, hemoptysis, chest pain, dyspnea, and exercise intolerance each have a structured pediatric differential. Practice working from the presenting complaint plus age to the most efficient next test. Questions often hinge on a single discriminating feature, such as wet versus dry cough, inspiratory versus expiratory noise, or onset in the neonatal period versus later childhood.
Core Principles of Pulmonary Diagnosis and Monitoring Techniques (8%)
Diagnostics You Must Be Able to Interpret
This is the domain where subspecialists are expected to read data fluently. Plan to interpret, not merely recognize, results.
- Spirometry patterns (obstructive, restrictive, mixed), bronchodilator response, and age-appropriate quality criteria.
- Lung volumes and diffusing capacity, and what a reduced DLCO does and does not suggest.
- Infant and preschool pulmonary function testing and its limitations.
- Bronchoscopy and bronchoalveolar lavage: indications, what cell patterns and cultures imply, and complications.
- Polysomnography, oximetry, blood gas interpretation, and imaging selection (chest radiograph, CT, and when each is appropriate).
- Sweat chloride and genetic testing basics as they relate to diagnostic algorithms.
Airway and Lung Disease Facts to Memorize
Cystic Fibrosis (6%) and Non-CF Bronchiectasis (4%)
Together these two domains are worth 10%, and they are conceptually linked: both involve chronic airway infection, impaired clearance, and structural damage. Keep the distinction clean, though.
Cystic Fibrosis
Know the disease from genetics through multisystem management.
- CFTR dysfunction and the logic behind modulator therapy, including how genotype determines eligibility.
- Newborn screening pathway, confirmatory sweat testing, and what to do with indeterminate results.
- Pulmonary exacerbation management, airway clearance, and chronic infection patterns including Pseudomonas, MRSA, and nontuberculous mycobacteria.
- Extrapulmonary disease: pancreatic insufficiency, CF-related diabetes, liver disease, distal intestinal obstruction, and nutrition.
Non-CF Bronchiectasis
The exam favors the etiologic workup.
- Primary ciliary dyskinesia: clinical clues (neonatal respiratory distress, chronic wet cough, chronic rhinosinusitis, laterality defects) and the diagnostic modalities used.
- Immunodeficiency, post-infectious causes, aspiration, and foreign body as contributors.
- Treatment principles: airway clearance, targeted antimicrobial strategy, and monitoring.
Respiratory Infections (6%)
Focus on pediatric-specific pathogens and syndromes: bronchiolitis, pneumonia (including complicated pneumonia with effusion or empyema), tuberculosis, pertussis, fungal and atypical infections, and infections in immunocompromised hosts. Stems commonly ask for the next best step in diagnosis or the appropriate antimicrobial choice and duration.
Interstitial and Restrictive Disease (5% each)
Childhood interstitial lung disease (chILD) differs substantially from adult ILD. Review neuroendocrine cell hyperplasia of infancy, surfactant protein and ABCA3 disorders, pulmonary interstitial glycogenosis, and the role of imaging and biopsy. For restrictive disease, connect chest wall and neuromuscular causes to restrictive physiology and to long-term respiratory support decisions.
Neonatal, Respiratory Failure, and Sleep/Control of Breathing
Respiratory Disorders of the Neonate and Infant (5%)
Think developmental trajectory.
- Bronchopulmonary dysplasia: definitions, pathophysiology, outpatient management, and pulmonary hypertension screening.
- Surfactant deficiency, meconium aspiration, persistent pulmonary hypertension of the newborn, and transient tachypnea.
- Long-term pulmonary outcomes of prematurity.
Respiratory Failure (5%)
Reason from physiology.
- Hypoxemic versus hypercapnic failure and the mechanisms behind each (V/Q mismatch, shunt, hypoventilation, diffusion limitation).
- Noninvasive ventilation, high-flow therapy, conventional and advanced ventilator strategies, and ARDS principles in children.
- Chronic ventilation and tracheostomy: indications, complications, and home-care considerations.
Sleep-Disordered Breathing and Control of Breathing Disorders (4%)
This domain pairs obstructive and central pathology.
- Obstructive sleep apnea: risk factors, polysomnographic criteria, adenotonsillectomy outcomes, and options for persistent disease.
- Congenital central hypoventilation syndrome and other central disorders, with the gene and clinical hallmarks you are expected to recognize.
- Hypoventilation in neuromuscular and chest wall disease, and when to initiate ventilatory support.
These three domains interlock. A child with Duchenne muscular dystrophy, for example, can generate a question touching restrictive disease, sleep-disordered breathing, and chronic respiratory failure in a single stem. Studying by system rather than by silo helps.
Smaller Domains That Still Cost Points
The 3-5% domains are where candidates lose avoidable points because they study them last and least. A short list of anchors:
- Congenital and Acquired Malformations of the Airways and Lungs (5%): congenital pulmonary airway malformation, sequestration, congenital diaphragmatic hernia, tracheoesophageal fistula, laryngomalacia, tracheomalacia, subglottic stenosis, and vascular rings and slings.
- Pulmonary Vascular and Lymphatic Diseases (4%): pediatric pulmonary hypertension classification and treatment, pulmonary embolism, alveolar hemorrhage syndromes, and chylothorax and lymphatic disorders.
- Lung Disease Associated with Systemic Disorders (4%): sickle cell acute chest syndrome, connective tissue and rheumatologic disease, inflammatory bowel disease, and post-transplant or oncologic lung complications.
- Environmental Injuries and Exposures, Acute and Chronic (4%): smoke and vaping-associated injury, inhalation injuries, drowning, aspiration of foreign bodies and hydrocarbons, and chronic air-pollution and secondhand-smoke effects.
- Respiratory System Under Stress (3%): exercise-induced bronchoconstriction, high-altitude effects, and the respiratory response to physiologic and clinical stressors.
- Other Disorders of the Respiratory System (5%): a catch-all domain; expect a mix of conditions that do not sit neatly elsewhere.
- Lung Development and Physiology (6%): stages of lung development, surfactant physiology, mechanics, gas exchange, and the regulation of ventilation.
- Core Knowledge in Scholarly Activities and Health Equity (4%): research design, biostatistics, interpreting evidence, quality improvement, and equity in access to pulmonary care. Do not neglect it; it is purely recall-and-reasoning points that many clinicians underprepare.
Scheduling Your Review by Domain Weight
Generic study methods matter less than allocating time where the points are. One practical approach is to sequence your final review by interlocking systems rather than by outline number, front-loading the heavy domains while saving room for the small ones. The timeline below is an example for an eight-week runway; adjust it to your calendar and to the November 5, 2026 exam date. For a full strategy, see our study guide for passing on the first attempt.
Asthma, Common Signs and Symptoms, Diagnostics
- Cover the three largest domains first (9%, 8%, 8%).
- Drill pulmonary function and polysomnography interpretation until reading data is automatic.
CF, Bronchiectasis, Infections, Interstitial and Restrictive Disease
- Study CF and PCD side by side to sharpen the distinction between them.
- Pair chILD with restrictive and neuromuscular physiology.
Neonatal, Respiratory Failure, Sleep/Control of Breathing, Malformations
- Work through prematurity-to-childhood trajectories, ventilation strategies, and airway anomalies.
Small Domains and Scholarly Content
- Pulmonary vascular, systemic-disease, environmental, stress physiology, and health equity and research methods.
Mixed Timed Practice
- Take mixed sets of multiple-choice questions under time pressure and review every miss against the outline.
Registration, Fees, and Eligibility Mechanics
Fee and Cost Basics
The official indexed regular fee is $2,992, which includes a $750 processing component. Treat this as the headline figure and confirm current amounts, deadlines, and any late or alternate fees directly with the ABP, since fee schedules are updated. The full pricing breakdown walks through the cost picture in detail, and if you are weighing the investment, our ROI analysis and salary guide cover the return side.
Eligibility in Brief
The traditional pathway requires a medical or osteopathic degree, general pediatrics certification, a three-year subspecialty fellowship, and completion of scholarly requirements. Two points need direct confirmation with the ABP rather than assumption: current license and attestation details, and whether the announced new training model applies to your situation. Our requirements guide lays out the prerequisites, and the exam dates page covers scheduling. The official date listing is at abp.org.
Exam-Day Rules: What Is Not Confirmed
Initial-certification rules on open-book access, calculator use, remote delivery, and breaks have not been verified for this article. Do not rely on rules from other exams or from the continuing-certification pathway. Check the ABP's candidate materials and your Prometric confirmation before test day.
After You Pass
Continuing certification runs on a five-year cycle, using either MOCA-Peds or an examination pathway. Plan for that ongoing commitment from the start. If you are mapping career options after certification, see the overview of pediatric pulmonology jobs; the usual employers are children's hospitals, academic medical centers, and pediatric subspecialty practices.
Key Takeaway
Because the weights are flat (3% to 9%), the winning strategy is breadth with depth in diagnostics. Master Asthma, Common Signs and Symptoms, and Core Principles of Pulmonary Diagnosis first, then ensure no smaller domain is left uncovered. To drill these areas with exam-style questions, use the Pediatric Pulmonology practice tests.
Frequently Asked Questions
The exam contains approximately 200 multiple-choice questions, administered through Prometric under the American Board of Pediatrics. Confirm the exact count and timing in the ABP's current candidate information.
The passing standard is a scaled score of 180 on a 1-300 scale. It is not a raw percentage of questions answered correctly, so you cannot convert it directly into a number of correct items. See our passing score guide for details.
Asthma is the largest published domain at 9%. Common Signs and Symptoms and Core Principles of Pulmonary Diagnosis and Monitoring Techniques follow at 8% each. Treat the outline weights as approximate, since versions may vary slightly.
The 19-domain content outline effective November 1, 2026 applies to the November 5, 2026 initial-certification examination. The October 2025 subboard approval date is not the effective date. Verify against the official ABP outline and version directory.
The latest verified first-time national pass rate is 73% for 2024, compared with 68% in 2022, as reported in a 2026 primary paper citing ABP data. It describes the national cohort and should not be read as a personal prediction.
Use this sheet as a map, not a substitute for depth. Pair it with the overview of the certification and the full domain guide, and check every date, fee, and rule against the ABP before you commit to a test window.